160 results on '"Mazzocco, Katia"'
Search Results
2. EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate
3. Evaluating HPV Viral Load and Multiple Infections for Enhanced Cervical Cancer Risk-Based Assessment.
4. 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
5. A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease
6. Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
7. Bovine Papillomavirus Type 1 Infection in an Equine Congenital Papilloma
8. Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results
9. Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
10. Abstract 3407: The italian personalized medicine program PREME for high-risk neuroblastoma
11. Genetic Abnormalities in Adolescents and Young Adults With Neuroblastoma: A Report From the Italian Neuroblastoma Group
12. Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
13. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)
14. Concomitant DDX1 and MYCN gain in neuroblastoma
15. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization
16. Molecular Genetics in Neuroblastoma Prognosis
17. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
18. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization
19. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases
20. Simultaneous tumors: Acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma
21. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
22. MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma†‡
23. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients
24. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma
25. Evidence of apoptosis in neuroblastoma at onset and relapse
26. Genetic alterations of ALK in high-risk neuroblastoma patients. A SIOPEN study
27. Neuroblastoma in adolescents: The Italian experience
28. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells
29. Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors
30. Additional file 1: of Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry
31. Two regions of deletion in 9p22∼p24 in neuroblastoma are frequently observed in favorable tumors
32. Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry
33. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
34. A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease.
35. Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease
36. Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
37. Neuroblastoma in Two Siblings Supports the Role of 1p36 Deletion in Tumor Development
38. Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
39. Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma
40. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy
41. Neuroblastoma in the Adult
42. Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.
43. A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma
44. Simultaneous tumors: Acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma
45. Neuroblastoma in adolescents
46. Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma
47. Real-Time Quantitative PCR for the Measurement of MYCN Amplification in Human Neuroblastoma with the TaqMan Detection System
48. Stage-independent expression and genetic analysis oftp73 in neuroblastoma
49. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome
50. Peculiar allelotype associated with susceptibility to neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.